This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Reply to “Prescribing Benzodiazepines for Patients With Substance Use Disorders”

Robin E. Clark, PhD; Haiyi Xie, PhD; Mary F. Brunette, MD

Published: November 1, 2004

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: We agree with Dr. Lieberman’s concern that precipitate intervention by policymakers might restrict appropriate use of benzodiazepines. That concern is clearly identified in our conclusions, in which we state, "It would be a mistake to adopt overly restrictive prescription policies." The larger question is, what, if any, role should government play in addressing the apparent discrepancy between guidelines developed by physicians and actual prescribing practice? Dr. Lieberman suggests that physicians can do better without policymakers’ involvement.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 65

Quick Links: